Agenus Inc (AGEN.O)

AGEN.O on Consolidated Issue listed on NASDAQ Capital Market

8.01USD
29 May 2015
Change (% chg)

$0.39 (+5.12%)
Prev Close
$7.62
Open
$7.61
Day's High
$8.05
Day's Low
$7.55
Volume
1,390,476
Avg. Vol
1,437,456
52-wk High
$8.09
52-wk Low
$2.56

AGEN.O

Chart for AGEN.O

About

Agenus Inc. including its subsidiaries (Agenus) is an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines and adjuvants. The Company’s core technology portfolio consists of Retrocyte Display technology platform and checkpoint modulator antibody programs (CPM... (more)

Overall

Beta: 1.72
Market Cap(Mil.): $628.71
Shares Outstanding(Mil.): 82.51
Dividend: --
Yield (%): --

Financials

  AGEN.O Industry Sector
P/E (TTM): -- 295.26 38.09
EPS (TTM): -0.95 -- --
ROI: -63.69 -5.72 15.45
ROE: -110.99 -6.68 16.49
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks